Q2 2019 Holdings
Filed 2019-08-14 | 43 holdings | $56.5M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Codexis Inc(CDXS) | COM | 192005106 | $24.9M | 1,350,000 | 44.0% |
| Axogen Inc(AXGN) | COM | 05463X106 | $17.8M | 900,000 | 31.5% |
| Acadia Pharmaceuticals Inc(ACAD) | COM | 004225108 | $5.3M | 200,000 | 9.5% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $4.8M | 220,000 | 8.6% |
| Aquestive Therapeutics Inc(AQST) | COM | 03843E104 | $2.5M | 590,000 | 4.4% |
| Crinetics Pharmaceuticals Inc(CRNX) | COM | 22663K107 | $900.0K | 36,000 | 1.6% |
| Harrow Health | COM | 45323A201 | $19.2K | 2,210,000 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $17.1K | 1,365,000 | 0.0% |
| Uniqure NV(QURE) | SHS | N90064101 | $16.0K | 205,000 | 0.0% |
| Odonate Therapeutics Inc | COM | 676079106 | $15.6K | 425,000 | 0.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $13.0K | 2,950,000 | 0.0% |
| Amarin Corp PLC | SPONSORED ADR | 023111206 | $12.5K | 645,000 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $11.8K | 125,000 | 0.0% |
| Cerecor Inc | COM | 15671L109 | $11.2K | 2,185,536 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $10.6K | 280,000 | 0.0% |
| PTC Therapeutics Inc(PTCT) | COM | 69366J200 | $10.2K | 226,388 | 0.0% |
| Cytokinetics | COM NEW | 23282W905 | $10.1K | 900,000 | 0.0% |
| TG Therapeutics Inc(TGTX) | COM | 88322Q108 | $9.9K | 1,150,000 | 0.0% |
| Eidos Therapeutics Inc(EIDXGBP) | COM | 28249H104 | $9.5K | 305,550 | 0.0% |
| Lexicon Pharmaceuticals Inc(LXRX) | COM NEW | 528872302 | $9.3K | 1,480,000 | 0.0% |
| Eton Pharmaceuticals Inc(ETON) | COM | 29772L108 | $8.5K | 1,075,000 | 0.0% |
| Magenta Therapeutics Inc | COM | 55910K108 | $7.9K | 535,000 | 0.0% |
| Tricida Inc(1T7) | COM | 89610F101 | $7.7K | 195,000 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $7.0K | 310,000 | 0.0% |
| Fibrogen Inc(FGENEUR) | COM | 31572Q808 | $6.8K | 150,000 | 0.0% |
| Biohaven Pharmaceutical Hldg(BHVN) | COM | G11196105 | $6.6K | 150,000 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $6.4K | 1,470,000 | 0.0% |
| Xoma Corp del(XOMA) | COM NEW | 98419J206 | $5.9K | 400,000 | 0.0% |
| Avenue Therapeutics Inc | COM NEW | 05360L205 | $5.9K | 930,000 | 0.0% |
| Ironwood Pharmaceutical Inc(IRWD) | COM CLASS A | 46333X108 | $5.7K | 525,400 | 0.0% |
| Vermillion Inc | COM NEW | 92407M206 | $3.8K | 4,250,000 | 0.0% |
| Zymeworks Inc | COM | 98985W102 | $3.7K | 170,000 | 0.0% |
| Strongbridge Biopharma PLC | COM | G85347105 | $3.6K | 1,140,000 | 0.0% |
| Fortress Biotech Inc | COM | 034960Q19 | $3.5K | 2,365,000 | 0.0% |
| Viking Therapeutics Inc(VKTX) | COM | 92686J106 | $3.3K | 400,000 | 0.0% |
| Aimmune Therapeutics Inc(AIMT) | COM | 00900T107 | $2.7K | 130,000 | 0.0% |
| Synthorx Inc | COM | 87167A103 | $2.1K | 157,600 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $1.5K | 51,000 | 0.0% |
| Fennec Pharmaceuticals Inc(FENC) | COM | 31447P100 | $1.2K | 295,000 | 0.0% |
| Arqule Inc(ARQLUSD) | COM | 04269E107 | $1.1K | 100,000 | 0.0% |
| Protalix Biotherapeutics Inc | COM | 74365A101 | $469 | 1,000,000 | 0.0% |
| Azurrx Biopharma Inc | COM | 05502L105 | $247 | 145,000 | 0.0% |
| Biolinerx LTD (Does not reflect a reverse stock split effectuated after June 30, 2019) | SPONSORED ADR | 09071M106 | $91 | 250,000 | 0.0% |